We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-12.87%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$13.9B
AUM Growth
-$8.15B
(-37%)
Cap. Flow
-$5.52B
Cap. Flow
% of AUM
-39.78%
Top 10 Holdings %
Top 10 Hldgs %
10.16%
Holding
2,006
New
392
Increased
427
Reduced
517
Closed
664
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar Tree
DLTR
|
+$107M |
| 2 |
Chubb
CB
|
+$107M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$91.9M |
| 4 |
Healthpeak Properties
DOC
|
+$90.9M |
| 5 |
Amazon
AMZN
|
+$86.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$150M |
| 2 |
CenterPoint Energy
CNP
|
+$133M |
| 3 |
Equifax
EFX
|
+$132M |
| 4 |
RTX Corp
RTX
|
+$110M |
| 5 |
Regions Financial
RF
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.16% |
| 2 | Consumer Discretionary | 12.71% |
| 3 | Real Estate | 9.83% |
| 4 | Healthcare | 9.38% |
| 5 | Technology | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIRX
926
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $915K | 0.01% |
62,857
| – | – |
|
927
Amneal Pharmaceuticals
AMRX
$5.79B
| $913K | 0.01% |
67,516
-4,958
| -7% | -$89.3K |
|
928
James River Group Holdings
JRVR
$217M
| $913K | 0.01% |
24,977
-1,789
| -7% | -$68.2K |
|
929
CVR Energy
CVI
$3.13B
| $907K | 0.01% |
26,314
-76,423
| -74% | -$2.91M |
|
930
FirstCash
FCFS
$8.78B
| $906K | 0.01% |
12,528
-1,797
| -13% | -$143K |
|
931
Qualys
QLYS
$6.35B
| $902K | 0.01% |
12,070
+4,381
| +57% | +$330K |
|
932
Editas Medicine
EDIT
$442M
| $889K | 0.01% |
+39,064
| New | +$1.06M |
|
933
APA Corp
APA
$13.2B
| $885K | 0.01% |
+33,721
| New | +$1.24M |
|
934
Kroger
KR
$34.8B
| $885K | 0.01% |
32,196
-15,048
| -32% | -$437K |
|
|
BBT
935
Beacon Financial Corp
BBT
$2.66B
| $882K | 0.01% |
32,715
+23,000
| +237% | +$773K |
|
936
GrafTech
EAF
$212M
| $882K | 0.01% |
7,714
+6,479
| +525% | +$989K |
|
937
Ranpak Holdings
PACK
$473M
| $878K | 0.01% |
+87,376
| New | +$859K |
|
938
Wintrust Financial
WTFC
$10.7B
| $877K | 0.01% |
+13,185
| New | +$1M |
|
|
GOLD
939
DELISTED
Randgold Resources Ltd
GOLD
| $872K | 0.01% |
10,514
+7,545
| +254% | +$609K |
|
|
PPLI
940
People Inc
PPLI
$3.1B
| $870K | 0.01% |
26,606
-51,965
| -66% | -$1.74M |
|
|
SYNH
941
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $864K | 0.01% |
21,954
-71,532
| -77% | -$3.32M |
|
942
Intel
INTC
$513B
| $858K | 0.01% |
18,292
+8,022
| +78% | +$376K |
|
|
RAD
943
DELISTED
Rite Aid Corporation
RAD
| $855K | 0.01% |
60,356
-26,316
| -30% | -$555K |
|
944
PUT
Upbound Group
UPBD
$1.16B
| $850K | 0.01% |
+52,500
| New | +$762K |
|
|
NVTA
945
DELISTED
Invitae Corporation
NVTA
| $849K | 0.01% |
76,742
+28,151
| +58% | +$365K |
|
946
ON Semiconductor
ON
$31.6B
| $844K | 0.01% |
51,099
+8,130
| +19% | +$141K |
|
|
MNTA
947
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $843K | 0.01% |
76,316
-382,671
| -83% | -$5.33M |
|
948
Extreme Networks
EXTR
$3.15B
| $842K | 0.01% |
137,998
+74,646
| +118% | +$433K |
|
949
LyondellBasell Industries
LYB
$19.2B
| $841K | 0.01% |
10,117
-766,779
| -99% | -$70.1M |
|
950
Eagle Bancorp
EGBN
$845M
| $835K | 0.01% |
+17,146
| New | +$872K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Balyasny Asset Management held 2,006 positions worth $13.9B, down 37% from $22B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Balyasny Asset Management withdrew a net $5.52B in Q4 2018, closing 664 positions and reducing 517 holdings. Its most notable exit was Equifax, an estimated $132M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Real Estate.
Against the trend, Balyasny Asset Management opened a new position in Aflac worth $83M.
- Balyasny Asset Management's largest Q4 2018 buy was Aflac: 1,821,849 shares worth $83M.
- Balyasny Asset Management added most to Dollar Tree in Q4 2018, an estimated $107M increase.
- Balyasny Asset Management's biggest Q4 2018 reduction was Wells Fargo, cutting an estimated $150M.
- Balyasny Asset Management fully exited Equifax in Q4 2018, selling an estimated $132M.
- Balyasny Asset Management's ten largest holdings make up 10% of its $13.9B portfolio in Q4 2018.
- Balyasny Asset Management opened 392 new positions and closed 664 in Q4 2018.
- Balyasny Asset Management's portfolio value fell 37% quarter-over-quarter to $13.9B.
Based on Balyasny Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.